Alucent Biomedical, Inc.
New Filing
CIK: 0001631834·Biotechnology·DELAWARE·Filed: Apr 20, 2023
Total Offering
$11,200,000
Amount Sold
$11,200,000
Investors
1
First Sale
Apr 17, 2023
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Myles Greenberg | Related Person |
| James Corbett | Related Person |
| Daniel Pelak | Related Person |
| Julie Lautt | Related Person |
| David Flicek | Related Person |
| Nick Pappas | Related Person |
| Colin Jackson | Related Person |
| James Isaacson | Related Person |
| Kevin Warner | Related Person |
| Henry Hauser | Related Person |
| Katalin Kauser | Related Person |
| Bruce Krattenmaker | Related Person |
Company
SEC Filing
0001631834-23-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free